TherapeuticsMD, Inc.
TXMD · Pharmaceutical Preparations
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Thompson Tommy G: Form 4
Insider disclosure · Filed · Report period 23 Dec 2025
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000025743 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- TXMD on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 951 Yamato Road, Suite 220, Boca Raton, FL, 33431
- Incorporated in
- NV
- Fiscal year end
- 31 December
- Former names on EDGAR
- AMHN, Inc. (to 14 Sep 2011), CROFF ENTERPRISES INC (to 04 Sep 2009), CROFF OIL CO (to 01 Apr 1997)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields